Getting the Market Right: Marc Lichtenfeld Explains PDUFA Dates
November 30, 2017
Today on Getting the Market Right, Marc Lichtenfeld explains the Prescription Drug User Fee Act (PDUFA) and the importance of PDUFA dates in biotech investing.
Are Self-Driving Cars Really in the Near Future?
July 21, 2017
Some commentators say that self-driving cars will be common by 2020. Our research suggests otherwise.
How to Invest in the Most Lucrative AI Stocks
May 31, 2017
AI stocks might seem too expensive for the average investor. But with the right ETF, you can own the major players for less than the cost of a tank of gas.
Catch the Next 10-Baggers on a Bull Run Like This
April 29, 2017
If you’re looking for an investment that already has 10-bagger status, look no further than NVIDIA stock.
Profit From the Next Tech War: The Race for 5G LTE
February 17, 2017
Now that 4G phone service is ubiquitous, companies are racing to develop 5G LTE service. You can profit from this upcoming tech war.
The Industry You’ll Feel Good About Investing In
June 9, 2014
There is a ready-made market for cutting-edge prosthetics – one that is expected to top $23.5 billion by 2017, thanks to the proliferation of joint disease, increased medical care in developing countries and an aging world population. Receiving the latest prosthetic may give recipients a new lease on life, but investing in the future of others can be an exciting affair, too.
What Biotech Investors Must Know Before PDUFA Dates
February 13, 2013
The most important day for a biotech company is the PDUFA date (pronounced puh-doo-fuh). It stands for Prescription Drug User Fee Act. The PDUFA date is the day the FDA votes to approve or reject a drug. Sometimes, the FDA will rule before the announced PDUFA date, but it’s the day by which a decision is expected.